Antipruritic treatments pt 2 Flashcards

1
Q

what steroid drug is most implicated in causing cat diabetes?

A

dexamethasone exhibits greater diabetogenic effects in cats than equipotent doses of prednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

long acting steroids
- how are they formulated
- recommended use in dogs and cats
- side effects

A
  • These contain insoluble vehicles (acetate, diacetate, acetonide)
  • These drugs are not recommended for routine use in the dog
  • When necessary, an exception can be made for the use of methylprednisolone acetate in the cat, where it can be used periodically with fewer side effects than in the dog, although side effects can occur that include skin fragility, diabetes and induction of demodicosis
  • possibly can contribute to development of congestive heart failure in the cat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

topical steroids duration of suppression after treatment is stopped:
- betamethasone valerate
- mometasone
- hydrocortisone aceponate

A
  • betamethasone valerate: <4wk
  • mometasone: no suppression after 7 days
  • hydrocortisone aceponate: no suppression after 70 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what affects potency of topical steroids? forms?

A
  • note that the potency of the steroid is affected by factors other than the type of steroid and its concentration (but these do affect potency too, of course)
  • eg. Molecular structure, absorption through the skin and the ability of the drug to leave the vehicle
  • ointment > cream > lotion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adverse effects linked with potent topical corticosteroid application:

A
  • cutaneous atrophy
  • comedones
  • superficial follicular cysts
  • Iatrogenic Cushing’s Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hydrocortisone aceponate
- type of drug and properties
-

A
  • diester class drug that allow penetration into the skin without much absorption
    <><>
  • lipophilic
  • Low plasma availability
  • Once inside the skin, transformed to deliver increased potency at the site of action with the systemic effects of hydrocortisone
    > significant anti-inflammatory activity
  • treat chronically affected areas daily for a week as per label instructions
    > and then maintain on no more than twice weekly application to the same location
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diprosone vs valisone effect on long-acting steroid potency

A
  • diprosone makes steroid more potent than valisone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

steroid ointment vs cream vs lotion potency

A

ointment > cream > lotion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

allergic otitis steroid therapy

A

2% Burow’s solution in propylene glycol with 1% hydrocortisone eardrops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Allergen-specific immunotherapy (ASIT)
- what is it, benefits
- success depends on?

A

allergy treatment that entails formulating an injection or sublingual treatment for allergic skin disease.
- one of the few treatments that offer the possible outcome of a long- term remission and is one of the best and safest long-term ways of managing allergies
- The idea is to induce tolerance in the patients to the allergens; this is a slow process, and the owners should be prepared for up to 12 months to assess the response
<><>
Success is dependant on
◦ the validity of the test
> quality control
> timing
◦ Extract formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when preparing ASIT, considerations to make sure formulation will be effective

A
  • Number of allergens per vial (<12)
  • cross-reactivity between allergens
  • Mold proteases (can affect pollens – 2 vials?)
  • What allergens are in high numbers in the environment during the pet’s allergy “season”
  • Potential for anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Injectable allergy extract can be formulated in several ways:

A

Aqueous, Emulsion and Alum precipitated extract are all available, also intralymphatic and sublingual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ASIT administration schedule, how it works

A

The allergens included in the extract are based on the test and the patient history and are administered to the patient using subcutaneous injections starting in lower volumes (and in some cases concentration) - called induction and then in increasing volumes to a maximum dose and frequency (called Maintenance) to induce tolerance in the patient to the allergens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sublingual immunotherapy (SLIT) pros and cons

A

Pros:
- used in animals that wont tolerate injections
- no reports of anaphylaxis (compared with injections)
- molds can be included with pollens (extract is stabilized with glycerin)

Cons:
- once to twice daily admin for life if it works - twice daily products may be preferable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oclacitinib - what is it?

A

It is a non-steroidal small molecule inhibitor of the Jak-Stat signalling pathways that affects Jak 1 and 3 and Erk 1 and 2 but not Stat 3. This leads to anti-inflammatory properties in particular affecting pruritus related to IL- 31
- non-steroidal treatment for allergic skin disease
- same spped of onset as prednisolone
- “apoquel”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

role of IL-31 in canine allergic skin disease

A
  • pruritic and pro-inflammatory cytokine
  • released by Th cells in response to stimulation
  • affects sensory nerves > itchyness
17
Q

How do JAK inhibitors work?

A

normally:
- cytokine binds to cell receptor > JAK activation > STAT phosphorylation > STAT dimerization > to nucleus > RNA polymerase transcription of DNA > leave nucleus > transcription > inflammatory cell function changes

JAK inhibitor stops JAK activation after cytokine binds receptor
> inhibitors only work in cells whose activity is mediated by cytokines that work through JAK

18
Q

Before starting long- term therapy with apoquel:

A
  • CBC
  • biochem
  • +/- urinalysis and urine culture
  • physical and dermatological evaluation
  • skin scraping for demodex
19
Q

Oclacitinib (Apoquel) treatment schedule

A
  • Day 0: Begin treatment as
    per label - 0.4 – 0.6 mg/kg PO twice daily for up to 14 days, and then once daily for maintenance therapy.
  • MILDLY ITCHY DOGS CAN START SID – pruritus scores at 28d were the same
  • may be administered with or without food
20
Q

Oclacitinib (Apoquel) should not be used in what animals?

A

NOT IN DOGS LESS THAN ONE YEAR – (young dogs: study stopped due to development of pneumonia, demodex)

21
Q

Oclacitinib (Apoquel) - what to warn owner about? what to do if no response?

A
  • warn owner about potential spike in itchiness when dose is decreased to once daily
  • if no response and compliant, consider alternative treatment or reassess diagnosis
22
Q

long-term Oclacitinib follow up:

A
  • every 6 - 12 months reassess patient
    > repeat CBC and biochem
    > +/- skin scraping if indicated
    > +/- urinalysis if indicated
23
Q

what is cytopoint?

A

A caninized IL-31 monoclonal antibody (mAb) treatment
- once monthly injection that is administered subcutaneously and tends to last 4-8 weeks.

24
Q

how are antibody therapies created?

A

immunize animals with target protein > isolate B-cells from the spleen or lymph node > identify cells that produce antibodies with desired binding properties to target > identify key DNA sequences from the desired antibodies > speciate the antibody > optimize the DNA sequences

25
Q

cytopoint admin, bioavailability, absorption

A
  • subcutaneous injection, therapeutic antibodies are injected into interstitial space.
  • There is 50-100% bioavailability
  • The therapeutic antibodies move from interstitial space into the bloodstream (and bind to IL-31) by several pathways.
    > They can be transported via lymphatics to blood,
    > absorbed directly into capillaries or
    > absorbed by receptor- mediated cell uptake (endocytosis) and transferred to the blood.
26
Q

cytopoint metabolism and clearance, implications for drug interactions

A

Clearance mechanisms include:
◦ Binding to target
◦ Anti-mAb antibodies in circulation
◦ Flow out of capillaries into interstitial space, taken up by cells and catabolized
<><>
- Therapeutic antibodies that attach to the FcRn (Fc neonatal receptor) within the endosome are protected from catabolization and are recycled back into the blood or lymph which extends half-life
- Antibodies are catabolized to peptides and amino acids within cells
<><>
These antibodies, therefore, are NOT metabolized by traditional metabolizing enzymes in the kidney or liver. As a result, drug-drug interactions rare. They are not converted into reactive or toxic metabolites. Antibodies are NOT excreted in urine by the kidneys

27
Q

what species is cytopoint for? how many injections

A
  • dogs only - caninized antibody
  • Some patients take multiple injections to take effect
28
Q

when should cytopoint be used? treatment schedule based on pruritus timing?

A

As Cytopoint is specific to only one aspect of allergic skin disease - IL-31 – and there are many mediators that come in to play after, the importance of anti-IL 31 treatment before subsequent inflammation develops has been suggested as a treatment protocol. This “proactive treatment” would suggest that patients be treated on a schedule and not when the pruritus starts to become intolerable

29
Q

When to choose Apoquel over Cytopoint?

A
  • In large dogs, the cost of therapy with CytopointTM is higher that Apoquel.
  • Apoquel may have activity against food allergies; effect of Cytopoint on food is currently unclear.
  • Apoquel should not be used in dogs < 3Kg or < 1 year old but Cytopoint can be used at all weights and sizes.
  • In cases of moderate to marked inflammation, Apoquel has greater anti-inflammatory action compared to Cytopoint.
  • Interestingly, in a paper published in December 2018, giant/large dogs had a better success rate with Cytopoint over smaller ones.
  • There are no drug interactions with Cytopoint and so it can be considered when age, medical or drug contraindications or concerns preclude the use of other treatments.
  • consider cytopoint when compliance could be an issue